Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Rubius Therapeutics, Inc. | 2,052,450 | reported | 24 Jul 2019 | tx 8+382,146−221,842 |
| Axcella Health Inc. | 40,000 | reported | 16 Nov 2022 | tx 1+40,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Nov 2022 | GRANT_AWARD | Axcella Health Inc. | 40,000 | 0.00 USD | deriv |
| 24 Jul 2019 | EXERCISE | Rubius Therapeutics, Inc. | 175,000 | 0.18 USD | |
| 24 Jul 2019 | EXERCISE | Rubius Therapeutics, Inc. | 32,146 | 0.19 USD | |
| 24 Jul 2019 | EXERCISE | Rubius Therapeutics, Inc. | 32,146 | 0.00 USD | deriv |
| 24 Jul 2019 | EXERCISE | Rubius Therapeutics, Inc. | 175,000 | 0.00 USD | deriv |
| 08 Apr 2019 | SALE | Rubius Therapeutics, Inc. | 2,100 | 20.00 USD | |
| 05 Apr 2019 | SALE | Rubius Therapeutics, Inc. | 12,096 | 20.00 USD | |
| 03 Apr 2019 | SALE | Rubius Therapeutics, Inc. | 500 | 20.00 USD | |
| 31 Jan 2019 | GRANT_AWARD | Rubius Therapeutics, Inc. | 175,000 | 0.00 USD | deriv |